Reasons for treating secondary AML as de novo AML.
Ostgård LS, Kjeldsen E, Holm MS, Brown Pde N, Pedersen BB, Bendix K, Johansen P, Kristensen JS, Nørgaard JM.
Ostgård LS, et al. Among authors: bendix k.
Eur J Haematol. 2010 Sep;85(3):217-26. doi: 10.1111/j.1600-0609.2010.01464.x. Epub 2010 Apr 29.
Eur J Haematol. 2010.
PMID: 20456491